81207 Bcr/abl1 gene minor bp
Also known as: BCR-ABL minor breakpoint, BCR-ABL p190 testing
Molecular analysis to detect BCR-ABL1 fusion with minor breakpoint (p190 fusion protein) in acute lymphoblastic leukemia and chronic myeloid leukemia.
In Plain Language
acute leukemia gene test; blood cancer translocation detection
Clinical Context
Used to identify minor breakpoint BCR-ABL1 fusion in acute lymphoblastic leukemia and accelerated phase chronic myeloid leukemia.
RVU Information
CPT 81207 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81207?
CPT 81207 (Bcr/abl1 gene minor bp) is a Pathology & Lab code. Molecular analysis to detect BCR-ABL1 fusion with minor breakpoint (p190 fusion protein) in acute lymphoblastic leukemia and chronic myeloid leukemia.
Who uses CPT code 81207?
CPT 81207 is used by Hematology, Oncology, Pathology. Used to identify minor breakpoint BCR-ABL1 fusion in acute lymphoblastic leukemia and accelerated phase chronic myeloid leukemia.
When is CPT 81207 used?
Used to identify minor breakpoint BCR-ABL1 fusion in acute lymphoblastic leukemia and accelerated phase chronic myeloid leukemia.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.